Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0QECGQ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
algM ADC
|
|||||
| Synonyms |
algM ADC
Click to Show/Hide
|
|||||
| Organization |
Technical University of Darmstadt.
|
|||||
| Drug Status |
Investigative
|
|||||
| Structure |
|
|||||
| Antibody Name |
Masked chicken-derived anti-IgM (aIgM) antibody
|
Antibody Info | Antigen Name |
Undisclosed
|
||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
DBCO-PEG4-Val-Cit-PABC
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through nucleophilic lysines.
|
|||||
General Information of The Activity Data Related to This ADC
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal Effective Concentration (EC50) |
0.66 nM
|
|||
| Method Description |
Cytotoxic effects of aIgM ADCs were evaluated by exposing IgM+ lymphoma B cells or off-target (IgM-) cells to different ADC concentrations. Cell viability was analyzed 72 h post ADC addition by a colorimetric method using CellTiter 96® AQueous One Solution Cell Proliferation Assay (Promega). Briefly, cells were seeded (1x104 cells/well) in a 96-well plate with the desired antibody concentrations ranging from 0.014-90 nM in a serial dilution. After 72 h, MTS solution was added to the cells and plate was incubated for 2 h. Absorption was measured at 490 nm using CLARIOstar plus microplate reader (BMG LABTECH). Cell proliferation was normalized to untreated control cell absorption values. The resulting curves were fitted with a variable slope four-parameter fit and EC50s were calculated using GraphPad Prism.
Click to Show/Hide
|
||||
| In Vitro Model | Burkitt lymphoma | Ramos cells | CVCL_0597 | ||
References
